Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Theravance Biopharma (TBPH) Misses Q4 EPS by 7c

February 23, 2022 4:29 PM EST

Theravance Biopharma (NASDAQ: TBPH) reported Q4 EPS of ($0.43), $0.07 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $14.9 million versus the consensus estimate of $13.77 million.

For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.

... More